Ouro Fino (Brazil) Today

OFSA3 Stock  BRL 21.39  0.09  0.42%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Ouro Fino is selling for under 21.39 as of the 4th of December 2024; that is 0.42% up since the beginning of the trading day. The stock's lowest day price was 21.0. Ouro Fino has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Ouro Fino Sade are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of November 2024 and ending today, the 4th of December 2024. Click here to learn more.
Ouro Fino Sade Animal Participaes S.A., together with its subsidiaries, operates in the animal health industry primarily in Brazil. Ouro Fino Sade Animal Participaes S.A. was incorporated in 1987 and is headquartered in Cravinhos, Brazil. OUROFINO SAON operates under Drug ManufacturersSpecialty Generic classification in Brazil and is traded on Sao Paolo Stock Exchange.. The company has 53.77 M outstanding shares. More on Ouro Fino Sade
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Ouro Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ouro Fino's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ouro Fino or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chief Executive OfficerDolivar Coraucci
Business ConcentrationHealth Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Ouro Fino Sade (OFSA3) is traded on Sao Paulo Exchange in Brazil and employs 17,952 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.44 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ouro Fino's market, we take the total number of its shares issued and multiply it by Ouro Fino's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ouro Fino Sade operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 53.77 M outstanding shares. Ouro Fino Sade has accumulated about 152.99 M in cash with 46.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.15.
Check Ouro Fino Probability Of Bankruptcy
Ownership Allocation
Ouro Fino owns a total of 53.77 Million outstanding shares. Ouro Fino holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 85.72 pct. of Ouro Fino Sade outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Ouro Ownership Details

Ouro Fino Sade Risk Profiles

Although Ouro Fino's alpha and beta are two of the key measurements used to evaluate Ouro Fino's performance over the market, the standard measures of volatility play an important role as well.

Ouro Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Ouro Fino without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Ouro Fino Corporate Executives

Elected by the shareholders, the Ouro Fino's board of directors comprises two types of representatives: Ouro Fino inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ouro. The board's role is to monitor Ouro Fino's management team and ensure that shareholders' interests are well served. Ouro Fino's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ouro Fino's outside directors are responsible for providing unbiased perspectives on the board's policies.
Fabio LopesCFO, Investor Relations Officer and Member of Executive BoardProfile

Additional Tools for Ouro Stock Analysis

When running Ouro Fino's price analysis, check to measure Ouro Fino's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ouro Fino is operating at the current time. Most of Ouro Fino's value examination focuses on studying past and present price action to predict the probability of Ouro Fino's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ouro Fino's price. Additionally, you may evaluate how the addition of Ouro Fino to your portfolios can decrease your overall portfolio volatility.